2.96
price up icon20.33%   0.50
after-market Dopo l'orario di chiusura: 2.99 0.03 +1.01%
loading

Phio Pharmaceuticals Corp Azioni (PHIO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
16.32%
2.209
1.899 2.776 2.547 3.602
Operating Income/Loss
16.32%
-2.209
-1.899 -2.776 -2.547 -3.602
Nonoperating Income/Loss
1,275%
0.055
0.004 -0.004 -0.002 -
Income/Loss From Continuing Operations Before Tax
13.67%
-2.154
-1.895 -2.78 -2.549 -3.602
Income/Loss From Continuing Operations After Tax
13.67%
-2.154
-1.895 -2.78 -2.549 -3.602
Net Income/Loss
13.67%
-2.154
-1.895 -2.78 -2.549 -3.602
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,385%
4.5801
0.3085 2.4402 1,728.49 1.1422
Diluted Average Shares
1,385%
4.5801
0.3085 2.4402 1,728.49 1.1422
Basic Earnings Per Share
176.47%
-0.47
-0.17 -1.14 -1.47 -3.15
Diluted Earnings Per Share
176.47%
-0.47
-0.17 -1.14 -1.47 -3.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):